Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0Q43
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,297
Award facts
- Contract value 100% obligated
- $2,296.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,296.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order falls under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply to Department of Defense healthcare facilities worldwide. No set-aside designation was applied to this award, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order was issued on January 13, 2026, with an ultimate completion date of January 14, 2026.
DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract under the PPV-G GEN V program with a $499.999 billion ceiling value extending through December 31, 2036. The contractor supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare operations. As one of multiple regional prime vendor contractors under this acquisition vehicle, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and consistent performance in delivering diverse pharmaceutical requirements to the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DU26F0Q43?
SPE2DU26F0Q43 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26F0Q43 worth?
The government has obligated $2,297 on SPE2DU26F0Q43.
Is contract SPE2DU26F0Q43 an order under another contract?
Yes. SPE2DU26F0Q43 is a delivery order under SPE2DU25D9809, an indefinite delivery contract.
Was contract SPE2DU26F0Q43 competed?
The extent of competition for SPE2DU26F0Q43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award